The global mammography equipment market is anticipated to grow significantly over the forecast period. Mammography refers to diagnostic and screening examinations conducted on human breasts to detect microcalcifications (tiny clusters of calcium). These tests use low energy X-rays and the primary goal of these tests is to detect early breast cancers, which is deemed to be the second leading cause of death in women.
Breast cancer is identified by the WHO as the leading cause of cancer in women. According to the estimates of WHO (World Health Organization), approximately 1.5 million cases of breast cancer were diagnosed in 2010 and this number is expected to double by 2030. Such rapidly rising incidence rates of breast cancer will serve the global mammography equipment market as a significant growth rendering driver. Moreover, the rising patient awareness levels on account of awareness programs organized by breast cancer charities will propel the growth of this market by encouraging women to undergo regular medical examinations. Some of the major charities and awareness campaigns organized in recent times include the observation of Breast Cancer Awareness Month (BCAM) every October and organizing fundraising programs such as the “Wear it Pink” day on 25th October 2013.
The future of this market will be fuelled by the presence of high unmet medical needs in emerging Asian and Latin American economies and the introduction of new products enabled with advanced technologies such as Hologic’s breast tomosynthesis (a 3D mammography system).
The 3D mammography equipment is identified as the fastest-growing market. Better image clarity aiding in an accurate diagnosis and the implementation of PACS (Picture Archiving and Communication Systems) eliminating costs associated with the usage and storage of X-ray films are some of the factors attributing to its high growth rates.
North America is expected to dominate the market throughout the forecast period. The presence of sophisticated reimbursement frameworks and high patient awareness levels account for the aforementioned conclusion. The European mammography equipment market follows North America in terms of market share on account of the presence of high breast cancer prevalence in countries such as Belgium, Denmark, and France coupled with high per capita healthcare expenditures in this region.
This research study encompasses a competitive landscape of the mammography equipment market. Revenue analysis, product benchmarking, and strategic developments of key market players, such as Hologic International, GE Healthcare, Phillips Healthcare, Fujifilm Holdings, Siemens Healthcare, and others are also provided in this report.
This report, by Grand View Research, takes a closer look at the mammography equipment industry, providing a holistic perspective on market dynamics, trends, supply and demand. The report deep-dives into the market and segments it on multiple levels and providing key insights on a macro as well as micro-level. The study aims at providing granular information, regarding estimates and forecasts for key product segments including screen film analog, 2D digital and 3D digital mammography equipment. The report also provides the same level of information for key regional markets.
This research report analyzes various factors, which have been driving and inhibiting the global mammography equipment market in the past. In addition, the report analyzes the impact of each driver and restraint on the market growth, which forms the base for the market forecast. The report also showcases the opportunities available in the market which may act as future drivers for the market.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent..."
Amongst the majorly used Covid-19 screening options, imaging is preferred by most healthcare professionals as it provides a primary diagnosis in a short time. All the imaging modalities including nuclear imaging have been used exhaustively to study Covid-19 and its effect on different patients in each demography. These are used in theories such as comparison of the vulnerability of pediatric and geriatric patients, and treatment response for several drug combinations. The rising requirement for advanced lung imaging solutions is expected to boost the development studies for lung phantoms. A detailed study on lung deterioration in Covid-19 patients is expected to provide advanced measures for early detection of the disease. The report will account for Covid19 as a key market contributor.